Delivery Order SPE2DR25D3020-SPE2DR26F9P0V
Award Date 11/17/25
Potential Completion Date 11/18/25
Potential Value $3.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, with a contract ceiling value of $3,394.93 and an ultimate completion date of November 17, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the prime contractor, which maintains its corporate office in Conshohocken, Pennsylvania—the designated place of performance....
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Oxymorphone HCL ER Tablets 20mg, valued at $11,664.15 under a firm fixed-price contract type. This non-competitive delivery order represents a single-item pharmaceutical procurement with an ultimate completion date of August 21, 2025. The award was made without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken,...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Oxymorphone HCL ER Tablets 20mg, valued at $11,133.62. This firm fixed-price delivery order, with an ultimate completion date of November 4, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside competitive procurement, reflecting AmerisourceBergen's continued capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets in quantities of 60 units, with a contract ceiling value of $1,216.15. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, and represents a non-competitive set-aside contract. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- On June 16, 2025, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order and is scheduled for completion by June 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Oxymorphone HCL ER 20 mg tablets (60-count packages) with a ceiling value of $2,869.54. This firm fixed-price delivery order, with an ultimate completion date of July 21, 2025, represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen Drug Corp's existing...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for Oxymorphone HCL ER Tablets 15mg, with a ceiling value of $1,404.26 and an ultimate completion date of August 25, 2025. This non-competitive, firm fixed-price delivery order represents a pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,198.34 to AmerisourceBergen Drug Corp for Oxymorphone HCL ER 20 mg tablets (60-count supply). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 2, 2025. The award was issued on August 29, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- This delivery order, awarded on July 23, 2025, authorizes AmerisourceBergen Drug Corp to supply Oxymorphone HCL ER Tablets 20mg to the Medical Supply Chain, a Defense Logistics Agency organization supporting the Department of Defense. The contract, with a ceiling value of $12,252.12 and a firm fixed price structure, represents a non-competitive set-aside delivery against a larger federal contract vehicle. Performance is scheduled for completion by July 24, 2025, with fulfillment occurring at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,311.06 on September 22, 2025, for the supply of Oxymorphone HCL Extended Release tablets (20mg) under a Firm Fixed Price contract with the Defense Logistics Agency's Medical Supply Chain. The contract is a non-set-aside award issued through competitive procurement and carries an ultimate completion date of September 23, 2025. Performance will be executed from the contractor's corporate office location in Conshohocken,...